vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in vTv Therapeutics Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +11 vs. Q1 2026
- Shares held
- 1.61M
- +119.9K (+8.1%) vs. Q1 2026
- Total value
- $60.5M
- +$1.52M (+2.6%) vs. Q1 2026
- New holders
- 17
- 6 more added
- Sold out
- 6
- 8 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.89M |
| Q4 2023 | 14 | $798.4K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $57.5M |
| Q3 2021 | 31 | $5.58M |
| Q2 2021 | 42 | $10.3M |
| Q1 2021 | 48 | $13.8M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 298,496 | $11.2M | 0.92% | 00.0% | Unchanged |
| Millennium Management LLC | 269,874 | $10.2M | 0.01% | +63,586+30.8% | Added |
| FMR LLC | 260,391 | $9.80M | 0.00% | 00.0% | Unchanged |
| Siren, L.L.C. | 163,000 | $6.14M | 0.12% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 148,314 | $5.58M | 0.03% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 94,463 | $3.56M | 0.00% | −14,459−13.3% | Reduced |
| Trails Edge Capital Partners, LP | 85,192 | $3.21M | 0.51% | −54,386−39.0% | Reduced |
| Aisling Capital Management LP | 50,000 | $1.88M | 0.40% | +50,000 | New |
| Marshall Wace, LLP | 39,560 | $1.49M | 0.00% | +26,171+195.5% | Added |
| Geode Capital Management, LLC | 32,470 | $1.22M | 0.00% | −416−1.3% | Reduced |
| Renaissance Technologies LLC | 17,454 | $657.1K | 0.00% | +17,454 | New |
| Vanguard Fiduciary Trust Co | 16,239 | $611.4K | 0.00% | +113+0.7% | Added |
| BlackRock, Inc. | 14,731 | $554.6K | 0.00% | +2,129+16.9% | Added |
| Jane Street Group, LLC | 13,703 | $515.9K | 0.00% | +13,703 | New |
| State Street Corp | 12,266 | $461.8K | 0.00% | +1,600+15.0% | Added |
| Two Sigma Investments, LP | 11,486 | $432.4K | 0.00% | +11,486 | New |
| Verdad Advisers, LP | 8,996 | $338.7K | 0.32% | +8,996 | New |
| Integrated Quantitative Investments LLC | 8,210 | $309.1K | 0.05% | +8,210 | New |
| Susquehanna International Group, LLP | 8,023 | $302.1K | 0.00% | +8,023 | New |
| Quadrature Capital Ltd | 6,305 | $237.4K | 0.00% | +6,305 | New |
| Trexquant Investment LP | 6,240 | $234.9K | 0.00% | +6,240 | New |
| Northern Trust Corp | 6,123 | $230.5K | 0.00% | −11,929−66.1% | Reduced |
| Pathstone Holdings, LLC | 6,073 | $228.7K | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 5,947 | $223.9K | 0.00% | +5,947 | New |
| HRT Financial LP | 5,923 | $223.0K | 0.00% | +5,923 | New |
| Citadel Advisors LLC | 5,906 | $222.4K | 0.00% | +5,906 | New |
| China Universal Asset Management Co., Ltd. | 2,500 | $94.1K | 0.01% | +2,500 | New |
| UBS Group AG | 2,175 | $81.9K | 0.00% | −3,461−61.4% | Reduced |
| BNP Paribas Arbitrage, SA | 1,802 | $67.8K | 0.00% | +1,793+19,922.2% | Added |
| Vanguard Global Advisers, LLC | 1,275 | $48.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,020 | $38.4K | 0.00% | −99−8.8% | Reduced |
| Morgan Stanley | 1,009 | $38.0K | 0.00% | −146−12.6% | Reduced |
| Valley National Advisers Inc | 980 | $36.9K | 0.00% | +980 | New |
| Farther Finance Advisors, LLC | 283 | $10.7K | 0.00% | 00.0% | Unchanged |
| Strengthening Families & Communities, LLC | 173 | $6.51K | 0.00% | 00.0% | Unchanged |
| State of Wyoming | 147 | $5.54K | 0.00% | +147 | New |
| Truvestments Capital LLC | 143 | $5.38K | 0.00% | +143 | New |
| Bessemer Group Inc | 112 | $4.00K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 50 | $1.88K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 45 | $1.69K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 38 | $1.43K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2 | $75 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 2 | $75 | 0.00% | +2 | New |
| Strategic Wealth Partners, Ltd. | 1 | $38 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3 | $0 | 0.00% | −40−93.0% | Reduced |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,350−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −7,531−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −5,618−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |